Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2026-11-19
IMTXImmatics N.V.Kramer RainerChief Business OfficerS - Sale+OE$6.06-22,8680-100%-$138,580
2026-11-19
RLAYRelay Therapeutics, Inc.Patel SanjivPres, CEOS - Sale$16.13-48,2021,310,002-4%-$777,498
2026-11-18
RLAYRelay Therapeutics, Inc.Bergstrom Donald APres, R, DS - Sale$16.51-10,269386,609-3%-$169,541
2026-11-18
RLAYRelay Therapeutics, Inc.Catinazzo ThomasCFOS - Sale$16.51-32,71770,948-32%-$540,158
2026-11-19
AIMAim Immunotech Inc.Equels Thomas KCEO, PresP - Purchase$0.13+50,000436,095+13%+$6,550
D
2026-11-17
LCTXLineage Cell Therapeutics, Inc.Broadwood Partners, L.P.Dir, 10%P - Purchase$0.77+1,000,000101,209,612+1%+$770,700
D
2026-11-17
BSEMBiostem Technologies, Inc.Matuszewski JasonCEO, 10%S - Sale+OE$1.00-14,3001,539,251-1%-$14,300
2026-11-17
PALIPalisade Bio, Inc.Baltera Robert Jr.DirP - Purchase$1.01+50,000511,904+11%+$50,285
2026-11-17
LCTXLineage Cell Therapeutics, Inc.Mulroy Michael H.DirP - Purchase$0.87+30,000328,555+10%+$26,100
D
2026-11-17
NBIXNeurocrine Biosciences IncLyons Gary ADirS - Sale+OE$164.87-15,000122,141-11%-$2,473,030
2026-11-17
AGMBAgomab Therapeutics NvEpstein David RDirP - Purchase$5.57+5,00059,980+9%+$27,850
2026-11-18
AIMAim Immunotech Inc.Equels Thomas KCEO, PresP - Purchase$0.13+20,000386,095+5%+$2,680
2026-11-17
TNYATenaya Therapeutics, Inc.Ali FarazCEOS - Sale$0.32-3,499536,283-1%-$1,122
2026-11-17
TNYATenaya Therapeutics, Inc.Tingley WhittemoreChief Medical OfficerS - Sale$0.32-3,223259,850-1%-$1,034
2026-11-16
REPLReplimune Group, Inc.Xynos KonstantinosChief Medical OfficerS - Sale$21.60-16,198208,017-7%-$349,877
2026-11-16
REPLReplimune Group, Inc.Schwendenman AndrewChief Accounting OfficerS - Sale$21.60-2,14897,277-2%-$46,397
2026-11-16
REPLReplimune Group, Inc.Patel SushilCEOS - Sale$21.60-49,026659,125-7%-$1,058,962
2026-11-16
REPLReplimune Group, Inc.Hill Emily LuisaCFOS - Sale$21.60-14,709201,143-7%-$317,714
2026-11-18
HALOHalozyme Therapeutics, Inc.Posard Matthew L.DirS - Sale$96.43-5,00048,609-9%-$482,147
D
2026-11-16
RVMDRevolution Medicines, Inc.Kelsey Stephen MichaelSee RemarksS - Sale+OE$167.87-27,160286,307-9%-$4,559,209
2026-11-16
ATRAAtara Biotherapeutics, Inc.Nguyen AnhcoPres, CEOS - Sale$6.46-6,094126,681-5%-$39,368
D
2026-11-16
WWBWindward Bio Group AGBonita David PDir, 10%P - Purchase$17.00+1,176,4717,097,483+20%+$20,000,007
D
2026-11-16
WWBWindward Bio Group AGOrbimed Advisors LLCDir, 10%P - Purchase$17.00+1,176,4717,097,483+20%+$20,000,007
2026-11-17
LXEOLexeo Therapeutics, Inc.Tamayo Louis EdwardCFOS - Sale$3.26-1,00791,900-1%-$3,283
2026-11-17
LXEOLexeo Therapeutics, Inc.Otero Jose ManuelCOOS - Sale$3.26-1,285137,003-1%-$4,189
2026-11-17
LXEOLexeo Therapeutics, Inc.Townsend Richard NolanCEOS - Sale$3.26-3,295373,483-1%-$10,742
DM
2026-11-16
MRNAModerna, Inc.Hoge StephenPresS - Sale+OE$215.63-78,3751,467,144-5%-$16,900,019
D
2026-11-16
WWBWindward Bio Group AGStampacchia OtelloDirP - Purchase$17.00+1,750,0005,338,520+49%+$29,750,000
2026-11-18
CGONCg Oncology, Inc.Kuan ArthurCEOP - Purchase$78.88+30,000228,916+15%+$2,366,425
2026-11-18
CGONCg Oncology, Inc.Kalofonos IsabelChief Commercial OfficerP - Purchase$79.76+3,7513,751New+$299,161
2026-11-17
ARTVArtiva Biotherapeutics, Inc.Miralles Gines DiegoPres, Head of R, DS - Sale$3.91-1,043121,457-1%-$4,080
2026-11-17
ARTVArtiva Biotherapeutics, Inc.Horan ChristopherChief Tech Operations OfficerS - Sale$3.91-20,546281,775-7%-$80,374
2026-11-17
ARTVArtiva Biotherapeutics, Inc.Bush JenniferCOO, CLO, Compliance OfficerS - Sale$3.91-19,217338,503-5%-$75,175
2026-11-16
TWSTTwist Bioscience CorpCho DennisSee RemarksS - Sale$103.69-5,42787,283-6%-$562,715
2026-11-16
TWSTTwist Bioscience CorpFinn Patrick JohnPres, COOS - Sale$103.69-12,752239,367-5%-$1,322,229
2026-11-16
TWSTTwist Bioscience CorpGreen PaulaSVP of HRS - Sale$103.69-4,281128,145-3%-$443,888
D
2026-11-16
TWSTTwist Bioscience CorpLeproust Emily M.CEOS - Sale+OE$103.69-19,045670,906-3%-$1,974,738
2026-11-16
TWSTTwist Bioscience CorpWerner Robert F.Chief Accounting OfficerS - Sale$103.69-1,63753,212-3%-$169,737
2026-11-16
TWSTTwist Bioscience CorpLaponis AdamCFOS - Sale$103.69-6,359126,329-5%-$659,352
2026-11-17
ARTVArtiva Biotherapeutics, Inc.Banerjee SubhashisChief Medical OfficerS - Sale$3.91-4,037164,701-2%-$15,792
2026-11-17
ARTVArtiva Biotherapeutics, Inc.Aslan FredCEOS - Sale$3.91-119,7711,337,657-8%-$468,532
2026-11-17
CMPXCompass Therapeutics, Inc.Lerner NeilCHIEF ACCOUNTING OFFICERP - Purchase$0.59+10,000430,000+2%+$5,900
2026-11-17
MGTXMeiragtx Holdings PlcForbes AlexandriaPres, CEOS - Sale$8.45-62,0001,239,595-5%-$523,900
D
2026-11-16
GILDGilead Sciences, Inc.Mercier JohannaChief Comm, Corp Aff OfficerS - Sale+OE$170.56-28,000110,684-20%-$4,775,527
2026-11-16
GILDGilead Sciences, Inc.Dickinson Andrew DCFOS - Sale$171.47-3,000158,096-2%-$514,410
2026-11-13
TARSTarsus Pharmaceuticals, Inc.Azamian Bobak R.Pres, CEO, Board ChairS - Sale$80.31-10,000851,412-1%-$803,100
2026-11-16
LCTXLineage Cell Therapeutics, Inc.Andrews Deborah JDirP - Purchase$0.80+25,00040,578+160%+$20,000
D
2026-11-16
CGONCg Oncology, Inc.Post Leonard EDirS - Sale+OE$92.00-1,0001,000-50%-$92,000
D
2026-11-13
VCELVericel CorpSiegal JonathanPrincipal Accounting OfficerS - Sale+OE$57.71-1,8851,259-60%-$108,779
2026-11-16
AIMAim Immunotech Inc.Equels Thomas KCEO, PresP - Purchase$0.14+38,000366,095+12%+$5,130
2026-11-16
LCTXLineage Cell Therapeutics, Inc.Culley Brian MPres, CEOP - Purchase$0.92+40,500296,016+16%+$37,098
D
2026-11-16
ADMAAdma Biologics, Inc.Guiheen Lawrence P.DirS - Sale+OE$13.92-10,000186,510-5%-$139,200
D
2026-11-16
ADMAAdma Biologics, Inc.Grossman Adam SPres, CEOS - Sale+OE$13.72-21,0003,789,160-1%-$288,120
DM
2026-11-12
HALOHalozyme Therapeutics, Inc.Torley HelenPres, CEOS - Sale+OE$100.01-60,000767,780-7%-$6,000,686
D
2026-11-13
FENCFennec Pharmaceuticals Inc.Brughera Marco MariaDirS - Sale+OE$12.00-20,0000-100%-$240,000
2026-11-12
TWSTTwist Bioscience CorpGreen PaulaSVP of HRS - Sale$0.00-20,429126,054-14%-$0
D
2026-11-12
GILDGilead Sciences, Inc.Kramer Kelly A.DirS - Sale+OE$169.76-10,3761,339-89%-$1,761,437
2026-11-13
AGMBAgomab Therapeutics NvEpstein David RDirP - Purchase$5.92+14,98054,980+37%+$88,679
DM
2026-11-11
ADPTAdaptive Biotechnologies CorpRubinstein JuliePres, COOS - Sale+OE$29.73-35,228377,802-9%-$1,047,303
2026-11-11
ADPTAdaptive Biotechnologies CorpBobulsky SusanChief Commercial Officer, MRDS - Sale$32.00-1,875387,4750%-$60,000
D
2026-11-11
RVMDRevolution Medicines, Inc.Anders JackCFOS - Sale+OE$188.10-35,750119,216-23%-$6,724,688
2026-11-11
EDITEditas Medicine, Inc.O'Neill Gilmore NeilCEOS - Sale$2.42-21,164265,592-7%-$51,122
2026-11-11
EDITEditas Medicine, Inc.Burkly LindaEVP, CHIEF SCIENTIFIC OFFICERS - Sale$2.42-7,81470,379-10%-$18,875
2026-11-11
ALDXAldeyra Therapeutics, Inc.Douglas RichardDirP - Purchase$0.64+200,000395,000+103%+$128,900
2026-11-12
CCCCC4 Therapeutics, Inc.Adams KendraCFOS - Sale$2.71-45,173337,150-12%-$122,487
D
2026-11-11
PCVXVaxcyte, Inc.Dhaliwal Harpreet S.Chief Technical Ops OfficerS - Sale+OE$67.83-17,00068,085-20%-$1,153,103
2026-11-11
AIMAim Immunotech Inc.Equels Thomas KCEO, PresP - Purchase$0.15+35,000328,095+12%+$5,215
DM
2026-11-09
VCELVericel CorpMara Joseph Anthony JrCFOS - Sale+OE$58.26-25,00816,186-61%-$1,456,978
D
2026-11-10
VCELVericel CorpMcLaughlin Kevin FDirS - Sale+OE$58.96-7,00018,300-28%-$412,720
D
2026-11-09
VCELVericel CorpZerbe Robert L MdDirS - Sale+OE$57.88-2,00032,995-6%-$115,760
D
2026-11-09
RVMDRevolution Medicines, Inc.Mancini AnthonySee RemarksS - Sale+OE$200.00-81139,765-2%-$162,200
D
2026-11-11
IMVTImmunovant, Inc.Pande AtulDirS - Sale+OE$36.00-3,000136,731-2%-$108,000
2026-11-10
DTILPrecision Biosciences IncScimeca DarioGCS - Sale$9.75-2,82156,782-5%-$27,505
2026-11-10
AIMAim Immunotech Inc.Equels Thomas KCEO, PresP - Purchase$0.14+39,000293,095+15%+$5,382
M
2026-11-06
ETRAElectra Therapeutics, Inc.Gordon Carl LDir, 10%P - Purchase$8.08+92,1162,194,579+4%+$744,531
M
2026-11-06
ETRAElectra Therapeutics, Inc.Orbimed Advisors LLCDir, 10%P - Purchase$8.08+92,1162,194,579+4%+$744,531
DM
2026-11-09
ADPTAdaptive Biotechnologies CorpRubinstein JuliePres, COOS - Sale+OE$29.82-23,762377,802-6%-$708,558
2026-11-09
REPLReplimune Group, Inc.Slattery Joseph PDirS - Sale$21.80-5,2001,467-78%-$113,360
2026-11-09
AIMAim Immunotech Inc.Equels Thomas KCEO, PresP - Purchase$0.16+31,298254,095+14%+$5,070
2026-11-06
GILDGilead Sciences, Inc.Cain Wettan Keeley MEVP GC, Legal, CompS - Sale$164.11-3,3995,360-39%-$557,810
DM
2026-11-05
VCELVericel CorpMara Joseph Anthony JrCFOS - Sale+OE$53.48-50,00016,186-76%-$2,674,019
2026-11-06
AIMAim Immunotech Inc.Equels Thomas KCEO, PresP - Purchase$0.16+12,751222,797+6%+$2,015
DM
2026-11-04
ADPTAdaptive Biotechnologies CorpRubinstein JuliePres, COOS - Sale+OE$26.78-35,643377,802-9%-$954,442
DM
2026-11-04
GILDGilead Sciences, Inc.O'Day Daniel PatrickCOB, CEOS - Sale+OE$175.16-112,429551,683-17%-$19,693,439
D
2026-11-05
CGEMCullinan Therapeutics, Inc.Michaelson JenniferChief Scientific OfficerS - Sale+OE$12.36-4,000158,649-2%-$49,440
M
2026-11-04
KODKodiak Sciences Inc.Baker Bros. Advisors LPDir, 10%P - Purchase$98.51+247,09020,424,859+1%+$24,340,836
D
2026-11-05
VCELVericel CorpSiegal JonathanPrincipal Accounting OfficerS - Sale+OE$52.90-1,5001,259-54%-$79,350
D
2026-11-05
VCELVericel CorpFlynn Sean C.GCS - Sale+OE$51.92-15,0001,990-88%-$778,800
DM
2026-11-04
VCELVericel CorpZerbe Robert L MdDirS - Sale+OE$49.12-5,50032,995-14%-$270,175
2026-11-06
AIMAim Immunotech Inc.Equels Thomas KCEO, PresP - Purchase$0.16+20,299210,046+11%+$3,167
2026-11-05
AGMBAgomab Therapeutics NvEpstein David RDirP - Purchase$6.90+15,00040,000+60%+$103,500
D
2026-11-05
ADMAAdma Biologics, Inc.Grossman Adam SPres, CEOS - Sale+OE$12.00-147,0003,795,160-4%-$1,764,000
M
2026-11-03
ETRAElectra Therapeutics, Inc.Gordon Carl LDir, 10%P - Purchase$7.63+472,5712,136,979+28%+$3,605,116
M
2026-11-03
ETRAElectra Therapeutics, Inc.Orbimed Advisors LLCDir, 10%P - Purchase$7.63+472,5712,136,979+28%+$3,605,116
2026-11-03
IPSCCentury Therapeutics, Inc.Carr DouglasSVP Finance, OperationsS - Sale$1.52-266502,6410%-$404
2026-11-03
TWSTTwist Bioscience CorpCho DennisSee RemarksS - Sale$135.40-94962,840-1%-$128,496
2026-11-03
TWSTTwist Bioscience CorpFinn Patrick JohnPres, COOS - Sale$135.40-2,565180,278-1%-$347,306
D
2026-11-03
TWSTTwist Bioscience CorpLeproust Emily M.CEOS - Sale+OE$135.40-4,573558,187-1%-$619,193
2026-11-03
TWSTTwist Bioscience CorpWerner Robert F.Chief Accounting OfficerS - Sale$135.40-14842,7690%-$20,039
2026-11-03
TWSTTwist Bioscience CorpGreen PaulaSVP of HRS - Sale$135.40-1,007105,625-1%-$136,350

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top